Tecon Biology Co Ltd
SZSE:002100
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.71
8.94
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Tecon Biology Co Ltd
Cash & Cash Equivalents
Tecon Biology Co Ltd
Cash & Cash Equivalents Peer Comparison
600438
000876
002157
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
T
|
Tecon Biology Co Ltd
SZSE:002100
|
Cash & Cash Equivalents
¥2.7B
|
CAGR 3-Years
19%
|
CAGR 5-Years
6%
|
CAGR 10-Years
25%
|
|
|
Tongwei Co Ltd
SSE:600438
|
Cash & Cash Equivalents
¥19B
|
CAGR 3-Years
59%
|
CAGR 5-Years
34%
|
CAGR 10-Years
35%
|
|
H
|
Heilongjiang Agriculture Co Ltd
SSE:600598
|
Cash & Cash Equivalents
¥4.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
93%
|
CAGR 10-Years
8%
|
|
B
|
Beijing Dabeinong Technology Group Co Ltd
SZSE:002385
|
Cash & Cash Equivalents
¥3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
8%
|
|
|
New Hope Liuhe Co Ltd
SZSE:000876
|
Cash & Cash Equivalents
¥9.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
21%
|
CAGR 10-Years
10%
|
|
|
Jiangxi Zhengbang Technology Co Ltd
SZSE:002157
|
Cash & Cash Equivalents
¥2.7B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
16%
|
See Also
What is Tecon Biology Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.7B
CNY
Based on the financial report for Jun 30, 2024, Tecon Biology Co Ltd's Cash & Cash Equivalents amounts to 2.7B CNY.
What is Tecon Biology Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
25%
Over the last year, the Cash & Cash Equivalents growth was -27%. The average annual Cash & Cash Equivalents growth rates for Tecon Biology Co Ltd have been 19% over the past three years , 6% over the past five years , and 25% over the past ten years .
You don't have any saved screeners yet
